What Bloodwork to Get Before Starting Peptides
Blood tests before peptide therapy aren't optional — they're the clinical foundation that separates safe, effective protocols from guesswork. Here's every panel you need, why you need it, and where to order without a doctor.
Before a single injection or capsule, you need a snapshot of where your body is right now. Without it, you can't measure whether a peptide protocol is working, you can't catch problems early, and you can't distinguish a peptide effect from something that was already happening.
This guide covers the baseline panels every peptide user should order, the additional markers specific to each peptide category, the monitoring schedule during and after a protocol, the red flags that require immediate attention, and where to order labs without a physician order.
The Universal Baseline: Every Peptide Protocol
Regardless of which peptide you're using, these panels form the minimum baseline. Think of them as your internal dashboard before starting the engine.
Comprehensive Metabolic Panel (CMP)
Covers 14 essential measurements: glucose, electrolytes (sodium, potassium, chloride, CO2), kidney function markers (BUN, creatinine, eGFR), liver enzymes (ALT, AST, ALP, bilirubin), and serum proteins (albumin, total protein). This is the broadest single test for organ function and metabolic health. Any peptide that affects metabolism, liver processing, or kidney clearance needs this as a baseline.
Complete Blood Count (CBC) with Differential
Red blood cells, white blood cells (with differential breakdown), hemoglobin, hematocrit, and platelets. Identifies anemia, infection, immune function, and clotting capacity. Certain peptides — particularly growth hormone secretagogues — can influence red blood cell production. You need to know your starting point.
Lipid Panel
Total cholesterol, LDL, HDL, triglycerides, and (ideally) VLDL. GLP-1 class medications and metabolic peptides directly affect lipid metabolism. Retatrutide and tirzepatide trials have shown significant triglyceride and LDL reductions. Without a baseline, you can't attribute changes to the protocol.
Fasting Glucose, Fasting Insulin, and HbA1c
Three angles on glucose metabolism. Fasting glucose gives a point-in-time snapshot. Fasting insulin reveals insulin resistance that glucose alone may miss. HbA1c provides a 2-3 month average of blood sugar. Growth hormone peptides (CJC-1295, Ipamorelin, MK-677) can increase blood glucose and insulin resistance. This is non-negotiable for that category.
Peptide-Specific Add-Ons
The universal baseline covers metabolic health. These add-on panels target the specific biological systems that each peptide category affects.
| Peptide Category | Examples | Additional Markers |
|---|---|---|
| GH Secretagogues | CJC-1295, Ipamorelin, MK-677, Tesamorelin | IGF-1, fasting glucose (recheck), fasting insulin |
| GLP-1 / Metabolic | Semaglutide, Tirzepatide, Retatrutide | Full thyroid panel (TSH, Free T3, Free T4), ApoB, amylase/lipase |
| Healing / Recovery | BPC-157, TB-500, GHK-Cu, KPV | CRP, ESR (inflammatory markers), liver panel recheck if extended use |
| Longevity / Anti-Aging | Epitalon, NAD+, MOTS-C | Hormone panel (testosterone, estradiol, DHEA-S), thyroid panel, CRP |
| Cognitive / Nootropic | Semax, Selank | Thyroid panel (TSH, Free T3, Free T4), cortisol (AM draw) |
IGF-1: The Growth Hormone Marker
If you're using any growth hormone secretagogue, IGF-1 is the single most important follow-up marker. Insulin-like Growth Factor 1 is produced by the liver in response to growth hormone and serves as the primary measurable proxy for GH-axis activity. It's more stable and easier to measure than GH itself, which pulses throughout the day.
A baseline IGF-1 tells you where your GH axis sits before intervention. Follow-up draws show whether the peptide is actually increasing GH output. A rising IGF-1 that pushes above the age-adjusted reference range warrants dose reduction — chronically elevated IGF-1 is associated with increased risk for certain conditions. This is why monitoring matters.
Thyroid Panel: The GLP-1 Requirement
FDA prescribing labels for GLP-1 class medications carry a boxed warning about thyroid C-cell tumors observed in animal studies. While the human relevance of this finding is debated, a baseline thyroid panel is standard of care before initiating GLP-1 therapy. TSH alone is insufficient — Free T3 and Free T4 provide a more complete picture of thyroid function that can detect subclinical issues TSH may miss.
Inflammatory Markers: The Healing Baseline
If you're using peptides for injury recovery or inflammation management — BPC-157, TB-500, KPV — baseline inflammatory markers give you objective data on whether the protocol is reducing inflammation. C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) are the standard markers. A high-sensitivity CRP (hs-CRP) test is more informative than standard CRP for subclinical inflammation.
The Monitoring Schedule
| Timing | What to Order | Purpose |
|---|---|---|
| Baseline (before starting) | Full panel: CMP + CBC + lipids + glucose/insulin/HbA1c + category-specific add-ons | Establish your personal starting point |
| 4–6 weeks in | Focused panel: CMP (liver/kidney check) + IGF-1 (for GH peptides) + any abnormal baseline markers | Catch early changes, confirm peptide is active |
| Every 8–12 weeks (ongoing) | Repeat focused panel + lipids + glucose | Track trends, adjust dosing, monitor safety |
| Post-protocol (4 weeks after stopping) | Full baseline repeat | Confirm return to normal, identify persistent changes |
If lab values are stable after two follow-up draws, extending to quarterly monitoring is reasonable for ongoing protocols. Always recheck sooner after a significant dose change. If you feel off — unusually fatigued, new symptoms, unexplained changes — get labs drawn regardless of the schedule.
Red Flags That Require Immediate Attention
A positive lab result doesn't always mean the peptide caused it — correlation isn't causation, especially with a single draw. But it does mean you need clinical evaluation before continuing. This is not optional, and it's not something an internet forum can diagnose for you.
Where to Order Labs Without a Doctor
Direct-to-consumer lab testing has made bloodwork accessible without a physician's office visit. You order online, visit a local draw site (typically Quest Diagnostics or Labcorp), and receive results digitally within 1–3 business days.
Availability varies by state. As of 2026, most US states permit direct-to-consumer lab ordering. States with restrictions or limitations include New York, New Jersey, Rhode Island, and Maryland, though regulations continue to evolve.
| Service | Network | Best For | Baseline Panel Cost |
|---|---|---|---|
| Ulta Lab Tests | Quest Diagnostics | Custom panel building, broad test menu | $75–250 |
| Marek Health | Quest Diagnostics | Peptide-specific panels, provider consultations available | $150–350 |
| InsideTracker | Quest Diagnostics | Longitudinal tracking, personalized reference ranges, optimization focus | $200–400 |
Cost ranges depend on which markers you include. A basic CMP + CBC + lipid panel runs $75–150. Adding IGF-1, thyroid, hormones, and inflammatory markers pushes toward $200–400. Some peptide telehealth providers bundle baseline labs into the program fee — ask before you duplicate testing.
How to Read Your Results
Lab results come with reference ranges, but standard reference ranges represent the population average — not the optimal range for someone on an active peptide protocol. A few interpretive notes specific to peptide therapy:
IGF-1: Reference ranges are age-stratified for a reason. An IGF-1 of 280 ng/mL might be mid-range for a 25-year-old and significantly elevated for a 55-year-old. Compare to your age-specific range, not the general range. The goal for GH peptide users is typically to bring IGF-1 to the upper quartile of the age-adjusted range — not above it.
Liver enzymes: Mild, transient elevations in ALT and AST can occur with many supplements and medications. What matters is the magnitude and the trend. A slight bump at the 4-week check that normalizes by the 12-week check is different from a progressive rise. Track the direction, not just the number.
Fasting glucose and insulin: GH secretagogues (especially MK-677) can raise fasting glucose by promoting insulin resistance. If your baseline glucose is already in the upper-normal range (90–99 mg/dL), GH peptides need extra caution and more frequent glucose monitoring.
CRP: Standard CRP has a wide reference range. High-sensitivity CRP (hs-CRP) is more useful for tracking subclinical inflammation. Values below 1.0 mg/L are considered low cardiovascular risk. Values between 1.0–3.0 are moderate. Above 3.0 warrants investigation — though acute infection, injury, or intense exercise can cause transient spikes.
The Source Quality Problem
There's a complication that most bloodwork guides don't address: the quality of the peptide you're using directly affects how to interpret your labs.
If your IGF-1 rises on a growth hormone peptide, was the dose appropriate, or was the vial three times stronger than the label claimed? If liver enzymes climb, is it the peptide, or a contaminant? If nothing changes at all, was the product underdosed or inactive?
Without a verified source — ideally with a certificate of analysis (COA) from a third-party lab confirming identity and purity — you're measuring the effect of an unknown quantity. This doesn't mean bloodwork is useless without COA verification, but it does mean that unexpected results should prompt questions about product quality alongside the clinical picture.
For more on navigating the sourcing landscape, see our guide on how compounding pharmacies work and the difference between 503A and 503B pharmacies.
The Bottom Line
Bloodwork is the single most valuable tool for running a peptide protocol safely. It gives you a starting point, confirms the peptide is doing something, catches problems before they become serious, and provides objective data where subjective experience is unreliable.
The minimum: CMP, CBC, lipids, fasting glucose/insulin, and HbA1c before you start anything. Add IGF-1 for growth hormone peptides, thyroid panel for GLP-1 medications, and inflammatory markers for healing protocols. Follow up at 4–6 weeks, then every 8–12 weeks.
Total cost for a comprehensive baseline through direct-to-consumer services: $150–400. That's a small price for the peace of mind and optimization data you get in return. If you can afford a peptide protocol, you can afford the labs to run it safely.